Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.67 billion. The enterprise value is $2.15 billion.
| Market Cap | 2.67B |
| Enterprise Value | 2.15B |
Important Dates
The last earnings date was Wednesday, February 26, 2025, after market close.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 121.45 million shares outstanding. The number of shares has increased by 9.84% in one year.
| Current Share Class | 121.45M |
| Shares Outstanding | 121.45M |
| Shares Change (YoY) | +9.84% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 6.26% |
| Owned by Institutions (%) | 81.38% |
| Float | 113.80M |
Valuation Ratios
The trailing PE ratio is 16.76 and the forward PE ratio is 15.54. CPRX's PEG ratio is 1.62.
| PE Ratio | 16.76 |
| Forward PE | 15.54 |
| PS Ratio | 5.29 |
| Forward PS | 4.74 |
| PB Ratio | 3.65 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | 11.15 |
| P/OCF Ratio | 11.12 |
| PEG Ratio | 1.62 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.24, with an EV/FCF ratio of 9.00.
| EV / Earnings | 13.13 |
| EV / Sales | 4.38 |
| EV / EBITDA | 9.24 |
| EV / EBIT | 11.03 |
| EV / FCF | 9.00 |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.17 |
| Quick Ratio | 4.83 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.38% and return on invested capital (ROIC) is 21.73%.
| Return on Equity (ROE) | 29.38% |
| Return on Assets (ROA) | 18.46% |
| Return on Invested Capital (ROIC) | 21.73% |
| Return on Capital Employed (ROCE) | 26.70% |
| Revenue Per Employee | $2.72M |
| Profits Per Employee | $905,464 |
| Employee Count | 181 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 4.01 |
Taxes
In the past 12 months, CPRX has paid $52.37 million in taxes.
| Income Tax | 52.37M |
| Effective Tax Rate | 24.22% |
Stock Price Statistics
The stock price has increased by +38.46% in the last 52 weeks. The beta is 0.84, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +38.46% |
| 50-Day Moving Average | 22.21 |
| 200-Day Moving Average | 19.92 |
| Relative Strength Index (RSI) | 48.22 |
| Average Volume (20 Days) | 1,080,845 |
Short Selling Information
The latest short interest is 5.72 million, so 4.71% of the outstanding shares have been sold short.
| Short Interest | 5.72M |
| Short Previous Month | 5.35M |
| Short % of Shares Out | 4.71% |
| Short % of Float | 5.02% |
| Short Ratio (days to cover) | 4.91 |
Income Statement
In the last 12 months, CPRX had revenue of $491.73 million and earned $163.89 million in profits. Earnings per share was $1.31.
| Revenue | 491.73M |
| Gross Profit | 421.11M |
| Operating Income | 195.12M |
| Pretax Income | n/a |
| Net Income | 163.89M |
| EBITDA | 232.90M |
| EBIT | 195.12M |
| Earnings Per Share (EPS) | $1.31 |
Balance Sheet
The company has $517.55 million in cash and $3.19 million in debt, giving a net cash position of $514.37 million or $4.24 per share.
| Cash & Cash Equivalents | 517.55M |
| Total Debt | 3.19M |
| Net Cash | 514.37M |
| Net Cash Per Share | $4.24 |
| Equity (Book Value) | 727.63M |
| Book Value Per Share | 6.02 |
| Working Capital | 502.93M |
Cash Flow
In the last 12 months, operating cash flow was $239.81 million and capital expenditures -$556,000, giving a free cash flow of $239.25 million.
| Operating Cash Flow | 239.81M |
| Capital Expenditures | -556,000 |
| Free Cash Flow | 239.25M |
| FCF Per Share | $1.97 |
Margins
Gross margin is 85.64%, with operating and profit margins of 39.68% and 33.33%.
| Gross Margin | 85.64% |
| Operating Margin | 39.68% |
| Pretax Margin | 43.98% |
| Profit Margin | 33.33% |
| EBITDA Margin | 47.36% |
| EBIT Margin | 39.68% |
| FCF Margin | 48.65% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.84% |
| Shareholder Yield | n/a |
| Earnings Yield | 6.14% |
| FCF Yield | 8.97% |
Analyst Forecast
The average price target for CPRX is $32.50, which is 48.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.50 |
| Price Target Difference | 48.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 12.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 12.66 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.66 |
| Piotroski F-Score | 5 |